https://orcid.org/0000-0003-3016-7242
Selected Grants
Pharmacological activation of a newly discovered KEAP1-ATF4-CHOP axis to select against targeted therapy resistance in NSCLC
ResearchResearch Assistant · Awarded by Department of Defense · 2024 - 2027Chromosomal Instability and 17p Loss Sensitize Cancer Cells to NDE1 Depletion
FellowshipPI-Fellow · Awarded by National Institutes of Health · 2024 - 2027External Relationships
- Hatteras Investment Partners, LLC
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.